Aptus Capital Advisors’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$158K Sell
14,444
-8,542
-37% -$93.8K ﹤0.01% 1153
2026
Q2
$211K Buy
22,986
+40
+0.2% +$446 ﹤0.01% 1099
2026
Q1
$249K Buy
22,946
+8,720
+61% +$74.6K ﹤0.01% 937
2025
Q4
$86.9K Buy
14,226
+57
+0.4% +$340 ﹤0.01% 1204
2025
Q3
$73.4K Buy
14,169
+106
+0.8% +$609 ﹤0.01% 1170
2025
Q2
$83.4K Sell
14,063
-2,106
-13% -$12.7K ﹤0.01% 1112
2025
Q1
$133K Sell
16,169
-7,328
-31% -$61.5K ﹤0.01% 965
2024
Q4
$194K Buy
23,497
+9,763
+71% +$78.3K ﹤0.01% 899
2024
Q3
$105K Buy
+13,734
New +$127K ﹤0.01% 846
2022
Q2
– Sell
-66,124
Closed -$1.02M – 720
2022
Q1
$1.02M Buy
+66,124
New +$834K 0.03% 251

Other funds holding PTEN

Aptus Capital Advisors's PTEN Position: Q3 2026 in Review

Aptus Capital Advisors reduced its Patterson-UTI (PTEN) stake by 37% in Q3 2026, selling an estimated $93.8K and leaving 14,444 shares worth $158K. The position accounts for ﹤0.01% of the portfolio, ranked #1153.

Aptus Capital Advisors first reported a position in PTEN in Q1 2022 and has held it in 10 quarters since. The position peaked at $1.02M in Q1 2022. 443 funds tracked by Wall St. Rank hold PTEN as of Q3 2026.

  • Aptus Capital Advisors held 14,444 shares of Patterson-UTI worth $158K as of Q3 2026.
  • Aptus Capital Advisors sold 8,542 Patterson-UTI shares in Q3 2026, an estimated $93.8K.
  • Patterson-UTI made up ﹤0.01% of Aptus Capital Advisors's portfolio in Q3 2026, its #1153 holding.
  • Aptus Capital Advisors first reported a position in Patterson-UTI in Q1 2022 and has held it in 10 quarters since.
  • Aptus Capital Advisors's Patterson-UTI position peaked at $1.02M in Q1 2022.
  • 443 funds tracked by Wall St. Rank held Patterson-UTI as of Q3 2026.

Based on Aptus Capital Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.